Structured expert elicitation course
Why is SEE valuable in healthcare decision making?
How were these materials developed?
The materials have been developed as a collaboration between the Centre for Health Economics (CHE), which co-authored the protocol for structured expert elicitation (SEE) funded by the Medical Research Council (MRC), and Lumanity, which regularly conducts SEE to support health technology assessment (HTA) and market access strategic planning.
The materials are based on the original MRC protocol and published SEE exercises in healthcare decision modelling.
How is SEE viewed by decision-makers?
"It is recommended that researchers continue to focus on identifying appropriate data sources for informing parameter estimates and, as elicitation methods continue to evolve, consider expert elicitation as a potential source of data for filling in gaps in the available information."
CADTH Guidelines for the Economic Evaluation of Health Technologies: Canada, 2017
"In the absence of empirical evidence from RCTs, non-randomised studies, or registries, or when considered appropriate by the committee taking into account all other available evidence, expert elicitation can be used to provide evidence ... Structured methods are preferred as they attempt to minimise biases and provide some indication of the uncertainty. Structured approaches should adhere to existing protocols (such as the Medical Research Council protocol)."
NICE Health Technology Evaluations: The Manual, 2022
Long-term survival in CKD (NICE TA775)
Cooke’s classical method to explore long-term survival in patients with CKD receiving placebo
• Calibration
• Online survey
• Aggregation
Anti-microbial resistance
York method to explore outcomes of specific infections following treatment with antimicrobials
• Online Survey
• Aggregation